🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

3,067 results for “Hospital” Clear

  1. Daratumumab Injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Immune Thrombocytopenia

    phase 2 small molecule active

    2 trials

  2. Darolutamide+ADT

    The First People's Hospital of Lianyungang

    Prostate Cancer

    phase 2 small molecule active

    1 trial

  3. Darovasertib

    Hospital Authority, Hong Kong

    Ocular Melanoma

    phase 2 small molecule completed

    1 trial

  4. Daunorubicin

    Hospital Authority, Hong Kong

    Down Syndrome

    phase 2 small molecule active

    1 trial

  5. Decitabine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    AML

    phase 2 small molecule terminated

    1 trial

  6. Decitabine

    Shanghai Tong Ren Hospital

    Acute Myeloid Leukemia

    phase 2 small molecule active

    1 trial

  7. Deep-sea fish oil

    The First People's Hospital of Lianyungang

    Radiation Toxicity

    phase 2 small molecule active

    1 trial

  8. Denosumab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lung Cancer

    phase 2 small molecule active

    1 trial

  9. Dental stent

    Hospital Authority, Hong Kong

    Nasopharyngeal Carcinoma

    phase 2 other active

    1 trial

  10. Dermatophagoides Farinae Drops Group 1

    The First People's Hospital of Lianyungang

    Atopic Dermatitis

    phase 2 mab completed

    1 trial

  11. Determine the ED50 and ED95 of esketamine

    The First People's Hospital of Lianyungang

    Intrauterine Polyp

    phase 2 small molecule active

    1 trial

  12. Dexamethasone

    The First People's Hospital of Lianyungang

    Precursor B-Cell Lymphoblastic Leukemia

    phase 2 small molecule active

    1 trial

  13. Dexamethasone

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    ITP

    phase 2 small molecule active

    1 trial

  14. Dexamethasone Combined with romiplostim N01

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Primary Immune Thrombocytopenia

    phase 2 small molecule active

    1 trial

  15. Dimethyl fumarate

    Xuanwu Hospital, Beijing

    Intracerebral Hemorrhage

    phase 2 small molecule terminated

    1 trial

  16. Dinutuximab

    Children's Hospital of Fudan University

    High Risk Neuroblastoma

    phase 2 mab active

    1 trial

  17. Disitamab Vedotin

    The First People's Hospital of Lianyungang

    HER2-positive Gastric Cancer

    phase 2 small molecule active

    1 trial

  18. Disitamab Vedotin (RC48)

    The First People's Hospital of Lianyungang

    Upper Tract Urothelial Carcinoma

    phase 2 small molecule active

    1 trial

  19. Docetaxel

    Hospital Authority, Hong Kong

    Non Small Cell Lung Cancer

    phase 2 small molecule completed

    1 trial

  20. Donafenib + Envafolimab

    Anhui Provincial Hospital

    Hepatocellular Carcinoma

    phase 2 small molecule active

    1 trial

  21. Donepezil Hydrochloride

    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

    Radiation Injuries

    phase 2 small molecule active

    1 trial

  22. Dose-attenuated IST and Hetrombopag

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Sever Aplastic Anaemia

    phase 2 small molecule active

    1 trial

  23. Dostarlimab

    Hospital Authority, Hong Kong

    Female

    phase 2 small molecule active

    1 trial

  24. Doxazosin 4 mg daily plus Celecoxib 200 mg every day (QD)

    Hospital Authority, Hong Kong

    Benign Prostatic Hyperplasia

    phase 2 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources